Bio-AMD, Inc., through its subsidiary, Bio AMD Holdings Limited, focuses on developing hand held electronic medical diagnostic devices. It offers point of care (POC) medical diagnostic products, including a disposable micro-fluidic test strip to measure prothrombin time/international normalized ratio through a POC blood coagulation monitoring device that enables patient based, anticoagulant drug therapy monitoring; and a digital strip reader to read various lateral flow based immunoassay diagnostic test strips in the areas of cardiac markers, infectious diseases, drugs of abuse, and female wellbeing. The company also provides disposable test strip combining micro-fluidics and ‘lab-on-chip’ technology, which offers quantitative measurement into a immunoassay POC platform that detects nanoparticles through magnetic manipulation. In addition, Bio-AMD, Inc., through its subsidiary, WOCU Limited, develops WOCU, a foreign exchange derivative quotation to mitigate currency risk that would be licensed into various corporate and retail financial based products, including exchange traded funds, indexed structured products, and derivatives. The company was formerly known as Flex Fuels Energy, Inc. and changed its name to Bio-AMD, Inc. in April 2011. Bio-AMD, Inc. was founded in 2006 and is based in Daresbury, the United Kingdom.